154 related articles for article (PubMed ID: 3260004)
1. Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling.
Lax I; Burgess WH; Bellot F; Ullrich A; Schlessinger J; Givol D
Mol Cell Biol; 1988 Apr; 8(4):1831-4. PubMed ID: 3260004
[TBL] [Abstract][Full Text] [Related]
2. Human epidermal growth factor receptor residue covalently cross-linked to epidermal growth factor.
Wu DG; Wang LH; Chi Y; Sato GH; Sato JD
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3151-5. PubMed ID: 1691502
[TBL] [Abstract][Full Text] [Related]
3. High-yield covalent attachment of epidermal growth factor to its receptor by kinetically controlled, stepwise affinity cross-linking.
Woltjer RL; Weclas-Henderson L; Papayannopoulos IA; Staros JV
Biochemistry; 1992 Aug; 31(32):7341-6. PubMed ID: 1324711
[TBL] [Abstract][Full Text] [Related]
4. Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site.
Wu DG; Wang LH; Sato GH; West KA; Harris WR; Crabb JW; Sato JD
J Biol Chem; 1989 Oct; 264(29):17469-75. PubMed ID: 2477372
[TBL] [Abstract][Full Text] [Related]
5. Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor.
Woltjer RL; Lukas TJ; Staros JV
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7801-5. PubMed ID: 1380167
[TBL] [Abstract][Full Text] [Related]
6. Localization by photoaffinity labeling of natriuretic peptide receptor-A binding domain.
McNicoll N; Gagnon J; Rondeau JJ; Ong H; De Léan A
Biochemistry; 1996 Oct; 35(39):12950-6. PubMed ID: 8841141
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of apolipoprotein B secretion by IL-6 is mediated by EGF or an EGF-like molecule in CaCo-2 cells.
Murthy S; Mathur S; Bishop WP; Field EJ
J Lipid Res; 1997 Feb; 38(2):206-16. PubMed ID: 9162741
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules.
Lax I; Bellot F; Howk R; Ullrich A; Givol D; Schlessinger J
EMBO J; 1989 Feb; 8(2):421-7. PubMed ID: 2785915
[TBL] [Abstract][Full Text] [Related]
9. A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor.
Kohda D; Odaka M; Lax I; Kawasaki H; Suzuki K; Ullrich A; Schlessinger J; Inagaki F
J Biol Chem; 1993 Jan; 268(3):1976-81. PubMed ID: 8420971
[TBL] [Abstract][Full Text] [Related]
10. Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions.
Kashles O; Szapary D; Bellot F; Ullrich A; Schlessinger J; Schmidt A
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9567-71. PubMed ID: 3264402
[TBL] [Abstract][Full Text] [Related]
11. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
[TBL] [Abstract][Full Text] [Related]
12. Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor.
Massague J; Czech MP; Iwata K; DeLarco JE; Todaro GJ
Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6822-6. PubMed ID: 6294655
[TBL] [Abstract][Full Text] [Related]
13. Six methods for direct radioiodination of mouse epidermal growth factor compared: effect of nonequivalence in binding behavior between labeled and unlabeled ligand.
Kienhuis CB; Heuvel JJ; Ross HA; Swinkels LM; Foekens JA; Benraad TJ
Clin Chem; 1991 Oct; 37(10 Pt 1):1749-55. PubMed ID: 1914179
[TBL] [Abstract][Full Text] [Related]
14. Chimeric receptor analyses of the interactions of the ectodomains of ErbB-1 with epidermal growth factor and of those of ErbB-4 with neuregulin.
Kim JH; Saito K; Yokoyama S
Eur J Biochem; 2002 May; 269(9):2323-9. PubMed ID: 11985614
[TBL] [Abstract][Full Text] [Related]
15. Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.
Lax I; Bellot F; Honegger AM; Schmidt A; Ullrich A; Givol D; Schlessinger J
Cell Regul; 1990 Jan; 1(2):173-88. PubMed ID: 2100196
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function.
Gullick WJ; Downward J; Waterfield MD
EMBO J; 1985 Nov; 4(11):2869-77. PubMed ID: 2415353
[TBL] [Abstract][Full Text] [Related]
17. Characterization of structural domains of the human epidermal growth factor receptor obtained by partial proteolysis.
Chinkers M; Brugge JS
J Biol Chem; 1984 Sep; 259(18):11534-42. PubMed ID: 6088549
[TBL] [Abstract][Full Text] [Related]
18. Identification of residues of the epidermal growth factor receptor proximal to residue 45 of bound epidermal growth factor.
Summerfield AE; Hudnall AK; Lukas TJ; Guyer CA; Staros JV
J Biol Chem; 1996 Aug; 271(33):19656-9. PubMed ID: 8702666
[TBL] [Abstract][Full Text] [Related]
19. Identification of residues in the nucleotide binding site of the epidermal growth factor receptor/kinase.
Russo MW; Lukas TJ; Cohen S; Staros JV
J Biol Chem; 1985 May; 260(9):5205-8. PubMed ID: 2985580
[TBL] [Abstract][Full Text] [Related]
20. EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain.
Hurwitz DR; Emanuel SL; Nathan MH; Sarver N; Ullrich A; Felder S; Lax I; Schlessinger J
J Biol Chem; 1991 Nov; 266(32):22035-43. PubMed ID: 1657987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
